Author:
Heidenreich A.,Rawal S.K.,Szkarlat K.,Bogdanova N.,Dirix L.,Stenzl A.,Welslau M.,Wang G.,Dawkins F.,de Boer C.J.,Schrijvers D.
Funder
Ortho Biotech Oncology Research and Development
Janssen Research & Development
Reference22 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease;Heidenreich;Eur Urol,2011
3. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Mottet;Eur Urol,2011
4. Second-line chemotherapy for advanced hormone-refractory prostate cancer;Garmey;Clin Adv Hematol Oncol,2008
5. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study;Berthold;J Clin Oncol,2008
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献